Medicare Enrolled
Dr. Lawrence Santora, M.D.
Interventional Cardiology · Orange, CA
Practice pattern: Cardiac & Electrophysiology
— Practice combining cardiac and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Santora from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Santora?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Santora
Dr. Lawrence Santora is an interventional cardiology specialist in Orange, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Santora performed 3,875 Medicare services across 2,794 unique beneficiaries.
Between the years covered by Open Payments, Dr. Santora received a total of $9,218 from 45 pharmaceutical and/or device companies across 406 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Santora is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 30% volume in CA
$9,218 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,875
Medicare services
Top 30% in CA for interventional cardiology
2,794
Unique beneficiaries
$122
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~204 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
815 | $104 | $278 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
762 | $12 | $32 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
355 | $40 | $122 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
243 | $22 | $55 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
240 | $47 | $124 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
240 | $200 | $531 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
175 | $169 | $451 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
128 | $102 | $241 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 114 | $417 | $1,050 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
93 | $60 | $156 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
76 | $50 | $128 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
70 | $140 | $358 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
68 | $76 | $222 |
| Cardiac catheterization | 62 | $208 | $593 |
| Nuclear stress test with CT scan A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan. |
57 | $1,742 | $4,400 |
| PET scan of heart muscle blood flow A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle. |
50 | $125 | $310 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
49 | $168 | $442 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
38 | $71 | $178 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
38 | $149 | $378 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
34 | $404 | $1,023 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
29 | $22 | $53 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
29 | $806 | $1,986 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
22 | $453 | $1,180 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
19 | $75 | $198 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
17 | $21 | $52 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
17 | $68 | $161 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
12 | $11 | $29 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
12 | $20 | $49 |
| Intravascular ultrasound of heart vessel, initial An ultrasound procedure used to evaluate a blood vessel within the heart during a diagnostic or treatment procedure. |
11 | $60 | $146 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
15.8% high complexity
29.7% medium
54.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,218
Total received (2018-2024)
Avg $1,317/year across 7 years
Top 41% in CA for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
406
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,453 (91.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$682 (7.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$84 (0.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,035
2023
$1,192
2022
$1,624
2021
$1,866
2020
$636
2019
$1,003
2018
$1,863
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ShockWave Medical, Inc
$191
Impulse Dynamics (USA) Inc.
$168
Novartis Pharmaceuticals Corporation
$149
Recor Medical Inc
$100
Abbott Laboratories
$97
ABIOMED
$91
Janssen Pharmaceuticals, Inc
$44
E.R. Squibb & Sons, L.L.C.
$40
SCPHARMACEUTICALS INC.
$36
Boehringer Ingelheim Pharmaceuticals, Inc.
$30
Regeneron Healthcare Solutions, Inc.
$21
Lilly USA, LLC
$18
Novo Nordisk Inc
$18
Medtronic, Inc.
$17
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$14
Top 3 companies account for 49.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,465
Impulse Dynamics (USA) Inc.
$850
SANOFI-AVENTIS U.S. LLC
$653
Boehringer Ingelheim Pharmaceuticals, Inc.
$636
ABIOMED
$513
PFIZER INC.
$469
Abbott Laboratories
$468
Amgen Inc.
$435
Cardiovascular Systems Inc.
$401
ShockWave Medical, Inc
$332
Janssen Pharmaceuticals, Inc
$307
BIOTRONIK INC.
$295
Kowa Pharmaceuticals America, Inc.
$234
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$221
ASAHI INTECC USA, INC.
$207
Gilead Sciences, Inc.
$181
Boston Scientific Corporation
$154
Penumbra, Inc.
$124
Medtronic, Inc.
$122
Kestra Medical Technology Services, Inc.
$119
Astellas Pharma US Inc
$106
Recor Medical Inc
$100
E.R. Squibb & Sons, L.L.C.
$99
Chiesi USA, Inc.
$81
Regeneron Healthcare Solutions, Inc.
$67
CVRx, Inc.
$60
SCPHARMACEUTICALS INC.
$52
ATRICURE, INC.
$50
Shockwave Medical, Inc
$46
iRhythm Technologies, Inc.
$42
HeartFlow, Inc.
$36
AstraZeneca Pharmaceuticals LP
$36
Cardinal Health 200, LLC
$31
Actelion Pharmaceuticals US, Inc.
$30
Amarin Pharma Inc.
$24
Bardy Diagnostics, Inc.
$22
PORTOLA PHARMACEUTICALS, INC.
$21
Lilly USA, LLC
$18
Allergan Inc.
$18
Novo Nordisk Inc
$18
Ultragenyx Pharmaceutical Inc.
$17
Medtronic Vascular, Inc.
$17
Akcea Therapeutics, Inc.
$15
Merck Sharp & Dohme LLC
$12
Esperion Therapeutics, Inc.
$11
Top 3 companies account for 32.2% of all-time payments
Associated products mentioned in payments ›
ANDEXXA · ASAHI PTCA Guide Wire · ATRICLIP LAA EXCLUSION SYSTEM · Assure WCD · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CHANTIX · CLEVIPREX · COREVALVE EVOLUT R · CardioMEMS HF System · Carnation Ambulatory Monitor · Corlanor · Coronary Orbital Atherectomy System · DRAGONFLY OPSTAR · Diamondback Coronary · Diamondback Peripheral · ELIQUIS · EMBLEM · EMBLEM S ICD ELECTRODE DELIVERY SYSTEM · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · EVKEEZA · FUROSCIX · GENERAL THERAPIES · HeartMate · HeartWare HVAD · ILARIS · Impella · Indigo · JARDIANCE · KENGREAL · LEQVIO · LEXISCAN · LINQ II · LifeVest · Livalo · MOUNJARO · MULTAQ · MitraClip System · NEXLIZET · OPSUMIT · OPTIS · Optimizer · Optimizer Smart System · Ozempic · PARADISE RENAL DENERVATION SYSTEM · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Perclose ProGlide suture mediated closure system · RESONATE · Repatha · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · TEGSEDI · VERQUVO · VYNDAQEL · Vascepa · Vascular Lithotripsy · WATCHMAN · XARELTO · ZIO Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Interventional cardiologists within 10 mi
66
Per 100K population
2.1
County median income
$113,702
Nearest hospital
PROVIDENCE ST. JOSEPH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Santora is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 30% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Santora experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Santora performed 815 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Santora receive payments from pharmaceutical companies?
Yes. Dr. Santora received a total of $9,218 from 45 companies across 406 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Santora's costs compare to other interventional cardiologists in Orange?
Dr. Santora's average Medicare payment per service is $122. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Santora) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Orange
Browse interventional cardiologists in Orange ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in CA
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in CA
Which CA interventional cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Impulse Dynamics (USA) Inc. Payments to Doctors
See all physicians who received payments from Impulse Dynamics (USA) Inc.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology